Cigna Group 8-K filings

The Cigna Group announced robust second quarter 2026 financial results, exceeding expectations and leading to an upward revision of its full-year earnings guidance.

The Cigna Group reaffirmed its projected full-year 2026 consolidated adjusted income from operations on a per share basis of at least $30.35.

The Cigna Group announced robust first-quarter 2026 results, with total revenues up 5% and adjusted income from operations increasing 12%, leading to an upward revision of its full-year earnings guidance.

The Cigna Group shareholders re-elected all twelve director nominees and ratified the appointment of PricewaterhouseCoopers LLP at the 2026 Annual Meeting.

The Cigna Group announced Brian C. Evanko will succeed David M. Cordani as CEO, effective July 1, 2026, while reaffirming its full-year 2026 financial outlook.

The Cigna Group reaffirms its projected full year 2026 consolidated adjusted income from operations of at least $30.25 per share.

The Cigna Group announced strong fourth quarter and full year 2025 results, increased its quarterly dividend, and provided its 2026 financial outlook.

The Cigna Group's Board of Directors approved significant changes to its committee structure, effective January 1, 2026, to align with strategic priorities and enhance corporate governance.

The Cigna Group announced strong third quarter 2025 results, with total revenues up 10% and reaffirmed its 2025 adjusted EPS outlook, alongside a new rebate-free pharmacy benefit model.

Retired Major General Elder Granger, M.D. will retire from The Cigna Group's Board of Directors effective December 31, 2025, in line with the company's retirement age policy.

The Cigna Group successfully completed a $4.5 billion senior notes offering to refinance debt and fund strategic investments.

The Cigna Group reaffirms its projected full year 2025 consolidated adjusted income from operations of at least $29.60 per share.

The Cigna Group announced strong second quarter 2025 financial results, with an 11% increase in total revenues and reaffirmed its 2025 adjusted EPS outlook of at least $29.60 per share.

The Cigna Group announced the appointment of Michael J. Hennigan to its Audit and Corporate Governance Committees, clarifying his board responsibilities.

The Cigna Group announced the appointment of Michael J. Hennigan, former CEO of Marathon Petroleum Corporation, as an independent member of its Board of Directors, effective June 2, 2025.

The Cigna Group reaffirms its projected full-year 2025 consolidated adjusted income from operations outlook of at least $29.60 per share during upcoming investor and analyst meetings.

The Cigna Group announced a 14% increase in total revenues for Q1 2025, reaching $65.5 billion, and raised its 2025 adjusted income from operations outlook to at least $29.60 per share.

The Cigna Group entered into a new $6.5 billion revolving credit agreement, replacing its existing facilities, and announced the resignation of its Global Chief Information Officer.

Eric P. Palmer, Executive Vice President for Enterprise Strategy and CEO of Evernorth Health Services, is departing The Cigna Group, with a separation agreement including a $5.2 million cash payment and continued vesting of certain equity awards.

The Cigna Group has completed the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC).

The Cigna Group announced leadership changes, including the appointments of Brian C. Evanko as President and COO and Ann M. Dennison as Executive Vice President and CFO, while reaffirming its 2025 financial outlook.

The Cigna Group reaffirms its projected full-year 2025 consolidated adjusted income from operations outlook of at least $29.50 per share during upcoming investor meetings.

The Cigna Group announced a 27% increase in 2024 revenue, a dividend increase, and a significant boost to its share repurchase program, despite challenges in its healthcare segment.

The Cigna Group announced a 30% increase in total revenue for the third quarter of 2024, reaching $63.7 billion, and reaffirmed its adjusted EPS outlook for the year.

The Cigna Group reaffirms its full-year 2024 adjusted income from operations outlook of at least $28.40 per share during upcoming investor meetings.

The Cigna Group announced a 25% increase in total revenue to $60.5 billion for the second quarter of 2024, alongside strong earnings growth.

The Cigna Group has appointed Jamie Kates as its new Chief Accounting Officer, effective July 1, 2024.

The Cigna Group reaffirms its full-year 2024 adjusted income from operations outlook of at least $28.40 per share and highlights its ongoing share repurchase program.

The Cigna Group announced strong first quarter 2024 results, driven by growth in both Evernorth and Cigna Healthcare, and increased its full-year earnings outlook.

Cigna Group held its annual shareholder meeting on April 24, 2024, where shareholders elected directors and voted on several proposals.